Coverage includes fertility tests, in vitro fertilisation treatments, hormonal treatments
Global healthcare company Merck has announced the expansion of its fertility benefits coverage to include employees in New Zealand.
The benefit is now available to eligible employees and their partners, “regardless of marital status and sexual orientation," said Rebecca Lee, managing director of Merck Life Science Australia and New Zealand, in a statement.
According to the managing director, services included in the benefit are fertility tests, in vitro fertilisation treatments, and hormonal treatments.
"In line with Merck's efforts to foster well-being and an environment where everyone feels they belong, the company also offers a robust suite of information and resources related to fertility and has created a dedicated space for a peer support network," Lee added.
New Zealand is just one of the 27 countries that will enjoy Merck's fertility benefits.
"We are so pleased that… we are able to support our people as they strive to realise their dream of parenthood," said Josie Downey, managing director of Merck Healthcare Australia and New Zealand, in a statement.
As of its latest expansion, Merck's fertility benefits now cover nearly 50 countries, including 98% of its global employee population, less than a year after it was introduced in October 2023.
